Founded by a team from MIT, Lamarr.AI uses drones, thermal imaging, and AI to help property owners make targeted investments in their buildings.
startups
-
Giving buildings an “MRI” to make them more energy-efficient and resilient
-
Demo Day features hormone-tracking sensors, desalination systems, and other innovations
MIT student teams celebrate business milestones at the capstone event for the 2025 delta v summer accelerator.
-
Accelerating hardware development to improve national security and innovation
The alumni-founded startup Nominal has built a platform for building and testing complex systems like fighter jets, nuclear reactors, rockets, and robots.
-
Startup’s biosensor makes drug development and manufacturing cheaper
Protein sensor developed by alumna-founded Advanced Silicon Group can be used for research and quality control in biomanufacturing.
-
MIT spinout maps the body’s metabolites to uncover the hidden drivers of disease
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
-
Creating smart buildings with privacy-first sensors
Butlr, founded by former Media Lab researchers, uses insights from thermal sensors to make buildings safe and efficient.
-
Startup’s autonomous drones precisely track warehouse inventories
Corvus Robotics, founded by Mohammed Kabir ’21, is using drones that can navigate in GPS-denied environments to expedite inventory management.
-
Startup gives surgeons a real-time view of breast cancer during surgery
The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.
-
Startup’s displays engineer light to create immersive experiences without the headsets
“We are adding a new layer of control between the world of computers and what your eyes see,” says Barmak Heshmat, co-founder of Brelyon and a former MIT postdoc.
-
A new way to spot life-threatening infections in cancer patients
Leuko, founded by a research team at MIT, is giving doctors a noninvasive way to monitor cancer patients’ health during chemotherapy — no blood tests needed.